Equatorial Guinea vs Monaco: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Equatorial Guinea
0.0%
in 2025
Monaco
0.0%
in 2025
Equatorial Guinea rank
167th
Monaco rank
167th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Equatorial Guinea
- Monaco
How they compare
Equatorial Guinea currently reports 0.0% against 0.0% in Monaco, a difference of 0.0%.
Across all 18 years both countries report, Monaco has been ahead every year.
Equatorial Guinea ranks 167th and Monaco ranks 167th of 194 countries.
Head to head by decade
| Decade | Equatorial Guinea | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Equatorial Guinea or Monaco?
- Equatorial Guinea, at 0.0% against 0.0% in Monaco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Equatorial Guinea and Monaco?
- 0.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Monaco?
- 18 years are reported by both, from 2008 to 2025.
- How do Equatorial Guinea and Monaco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Equatorial Guinea ranks 167th and Monaco ranks 167th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.